These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16026650)

  • 1. Two-mechanism peak concentration model for cellular pharmacodynamics of Doxorubicin.
    El-Kareh AW; Secomb TW
    Neoplasia; 2005 Jul; 7(7):705-13. PubMed ID: 16026650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular PK/PD Relationships of Free and Liposomal Doxorubicin: Quantitative Analyses and PK/PD Modeling.
    Soininen SK; Vellonen KS; Heikkinen AT; Auriola S; Ranta VP; Urtti A; Ruponen M
    Mol Pharm; 2016 Apr; 13(4):1358-65. PubMed ID: 26950248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mathematical model for cisplatin cellular pharmacodynamics.
    El-Kareh AW; Secomb TW
    Neoplasia; 2003; 5(2):161-9. PubMed ID: 12659689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Predictive Mathematical Modeling Approach for the Study of Doxorubicin Treatment in Triple Negative Breast Cancer.
    McKenna MT; Weis JA; Barnes SL; Tyson DR; Miga MI; Quaranta V; Yankeelov TE
    Sci Rep; 2017 Jul; 7(1):5725. PubMed ID: 28720897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyethylene glycol-complexed cationic liposome for enhanced cellular uptake and anticancer activity.
    Jung SH; Jung SH; Seong H; Cho SH; Jeong KS; Shin BC
    Int J Pharm; 2009 Dec; 382(1-2):254-61. PubMed ID: 19666094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxorubicin-loaded biodegradable self-assembly zein nanoparticle and its anti-cancer effect: Preparation, in vitro evaluation, and cellular uptake.
    Dong F; Dong X; Zhou L; Xiao H; Ho PY; Wong MS; Wang Y
    Colloids Surf B Biointerfaces; 2016 Apr; 140():324-331. PubMed ID: 26764113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship between cytotoxic drug exposure and tumour cell kill, in vitro and in vivo.
    Kerr DJ; Smart HE
    In Vivo; 1991; 5(4):385-8. PubMed ID: 1810425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinatorial effects of doxorubicin and retargeted tissue factor by intratumoral entrapment of doxorubicin and proapoptotic increase of tumor vascular infarction.
    Stucke-Ring J; Ronnacker J; Brand C; Höltke C; Schliemann C; Kessler T; Schmidt LH; Harrach S; Mantke V; Hintelmann H; Hartmann W; Wardelmann E; Lenz G; Wünsch B; Müller-Tidow C; Mesters RM; Schwöppe C; Berdel WE
    Oncotarget; 2016 Dec; 7(50):82458-82472. PubMed ID: 27738341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring doxorubicin cellular uptake and trafficking using in vitro Raman microspectroscopy: short and long time exposure effects on lung cancer cell lines.
    Farhane Z; Bonnier F; Byrne HJ
    Anal Bioanal Chem; 2017 Feb; 409(5):1333-1346. PubMed ID: 27888307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling of the time-dependency of in vitro drug cytotoxicity and resistance.
    Levasseur LM; Slocum HK; Rustum YM; Greco WR
    Cancer Res; 1998 Dec; 58(24):5749-61. PubMed ID: 9865733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular accumulation and mechanism of action of doxorubicin in a spatio-temporal tumor model.
    Jackson TL
    J Theor Biol; 2003 Jan; 220(2):201-13. PubMed ID: 12468292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting CD44 expressing cancer cells with anti-CD44 monoclonal antibody improves cellular uptake and antitumor efficacy of liposomal doxorubicin.
    Arabi L; Badiee A; Mosaffa F; Jaafari MR
    J Control Release; 2015 Dec; 220(Pt A):275-286. PubMed ID: 26518722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mathematical model of doxorubicin penetration through multicellular layers.
    Evans CJ; Phillips RM; Jones PF; Loadman PM; Sleeman BD; Twelves CJ; Smye SW
    J Theor Biol; 2009 Apr; 257(4):598-608. PubMed ID: 19183560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A tumor cord model for doxorubicin delivery and dose optimization in solid tumors.
    Eikenberry S
    Theor Biol Med Model; 2009 Aug; 6():16. PubMed ID: 19664243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and -nonspecific drugs.
    Gardner SN
    Cancer Res; 2000 Mar; 60(5):1417-25. PubMed ID: 10728708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: in vitro and in vivo.
    Xiong XB; Huang Y; Lu WL; Zhang X; Zhang H; Nagai T; Zhang Q
    J Pharm Sci; 2005 Aug; 94(8):1782-93. PubMed ID: 15986461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spray-dried doxorubicin-albumin microparticulate systems for treatment of multidrug resistant melanomas.
    Jones AK; Bejugam NK; Nettey H; Addo R; D'Souza MJ
    J Drug Target; 2011 Jul; 19(6):427-33. PubMed ID: 20678033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cytotoxicity profile and intracellular localisation of doxorubicin-loaded chitosan nanoparticles.
    Souto GD; Farhane Z; Casey A; Efeoglu E; McIntyre J; Byrne HJ
    Anal Bioanal Chem; 2016 Aug; 408(20):5443-55. PubMed ID: 27225177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake.
    Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J
    Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-mediated combination chemotherapy and photodynamic therapy overcomes tumor drug resistance in vitro.
    Khdair A; Handa H; Mao G; Panyam J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):214-22. PubMed ID: 18796331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.